Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study (Q71727922)
Jump to navigation
Jump to search
scientific article published on 01 November 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study |
scientific article published on 01 November 1996 |
Statements
Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study (English)
P Sonneveld
J P Marie
C Huisman
A Vekhoff
M Schoester
A M Faussat
J van Kapel
A Groenewegen
S Charnick
R Zittoun
1 November 1996